Jun 30, 2025, 12:50

DoD FY25 Melanoma Survivorship Research Award

Supports innovative research to improve long-term health, quality of life, and well-being of melanoma survivors, their families, and caregivers—encompassing clinical trials, behavioral interventions, and survivorship strategies tailored to the unique needs of this population .

Eligibility Criteria:

Applicant Organizations: Extramural or intramural U.S. or foreign academic institutions, biotech companies, foundations, DOD laboratories, and other public or private entities (for-profit and non-profit).
Principal Investigator: Independent investigator at any career level; mentored positions (postdocs, fellows) are not eligible as PI.
Melanoma Consumer Collaboration: Must include ≥1 melanoma survivor, family member, caregiver, or melanoma-community organization as active research partner.
Research Scope: Broad range of survivorship research (physical, psychological, social, economic effects); clinical trials allowed; purely animal studies or survival-only endpoints without quality-of-life considerations are not responsive.
Cost Sharing: Not required.

Funding Details:

Total Pool: ≈ 2.03 USD million to fund ~2 awards
Award Cap: Up to 1.015 USD million total costs (direct + indirect) per award over a maximum 3-year period; funds expire September 30, 2031; awards made no later than September 30, 2026.
Allowable Costs: Personnel, supplies, equipment, multi-institutional travel, one scientific meeting per year, participant compensation, data/resource sharing; indirect costs per negotiated rate; no tuition.

Deadline:

Letter of Intent (Pre-Application): September 10, 2025 by 5:00 p.m. ET
Full Application: October 1, 2025 by 11:59 p.m. ET
Verification Period Ends: October 7, 2025 by 5:00 p.m. ET
Peer Review: December 2025
Programmatic Review: February 2026

Where to Go for Further Information & Application:

eBRAP Portal (intramural & pre-application).
Guidelines.
Grants.gov Workspace (extramural full application): search Funding Opportunity Number HT942525MRPSRA.